Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 10, 2013Biology of Blood and Marrow TransplantationOpen Access

Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

LCLuciano J. CostaUniversity of Alabama at BirminghamMZMei-Jie ZhangMedical College of WisconsinXZXiaobo ZhongBristol-Myers Squibb (Germany)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Costa et al. (2013) studied this question.

synapsesocial.com/papers/6a96edd918aea7995cf6a807https://doi.org/10.1016/j.bbmt.2013.08.002
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bortezomib Plus Dexamethasone Is Superior to Vincristine Plus Doxorubicin Plus Dexamethasone As Induction Treatment Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Results of the IFM 2005-01 Phase III Trial2010 · 533 citations
  2. 2Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma2004 · 817 citations
  3. 3High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma2003 · 1,774 citations
  4. 4Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis2008 · 127 citations
  5. 5Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma2003 · 978 citations